TARS logo

Tarsus Pharmaceuticals, Inc. (TARS) Cash From Investing

Annual CFI:

-$199.19M-$339.80M(-241.67%)
December 31, 2024

Summary

  • As of today, TARS annual cash from investing is -$199.19 million, with the most recent change of -$339.80 million (-241.67%) on December 31, 2024.
  • During the last 3 years, TARS annual cash from investing has fallen by -$198.61 million (-33892.32%).
  • TARS annual cash from investing is now -241.67% below its all-time high of $140.60 million, reached on December 31, 2023.

Performance

TARS Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTARScash flow metrics

Quarterly CFI:

-$4.74M+$46.96M(+90.83%)
September 30, 2025

Summary

  • As of today, TARS quarterly cash from investing is -$4.74 million, with the most recent change of +$46.96 million (+90.83%) on September 30, 2025.
  • Over the past year, TARS quarterly cash from investing has dropped by -$7.87 million (-251.63%).
  • TARS quarterly cash from investing is now -107.40% below its all-time high of $64.09 million, reached on June 30, 2023.

Performance

TARS Quarterly Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTARScash flow metrics

TTM CFI:

-$150.96M-$7.87M(-5.50%)
September 30, 2025

Summary

  • As of today, TARS TTM cash from investing is -$150.96 million, with the most recent change of -$7.87 million (-5.50%) on September 30, 2025.
  • Over the past year, TARS TTM cash from investing has dropped by -$29.19 million (-23.97%).
  • TARS TTM cash from investing is now -207.37% below its all-time high of $140.60 million, reached on December 31, 2023.

Performance

TARS TTM Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTARScash flow metrics

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

TARS Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-241.7%-251.6%-24.0%
3Y3 Years-10000.0%+91.7%-161.7%
5Y5 Years-10000.0%--

TARS Cash From Investing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-241.7%at low-107.4%+95.4%-207.4%+24.2%
5Y5-Year-241.7%at low-107.4%+95.4%-207.4%+24.2%
All-TimeAll-Time-241.7%at low-107.4%+95.4%-207.4%+24.2%

TARS Cash From Investing History

DateAnnualQuarterlyTTM
Sep 2025
-
-$4.74M(+90.8%)
-$150.96M(-5.5%)
Jun 2025
-
-$51.70M(-48.0%)
-$143.09M(-8.5%)
Mar 2025
-
-$34.94M(+41.3%)
-$131.91M(+33.8%)
Dec 2024
-$199.19M(-241.7%)
-$59.57M(-2004.5%)
-$199.19M(-63.6%)
Sep 2024
-
$3.13M(+107.7%)
-$121.77M(-57.1%)
Jun 2024
-
-$40.52M(+60.4%)
-$77.53M(-386.2%)
Mar 2024
-
-$102.22M(-672.7%)
$27.09M(-80.7%)
Dec 2023
$140.60M(+197.2%)
$17.85M(-62.3%)
$140.60M(+295.7%)
Sep 2023
-
$47.37M(-26.1%)
$35.53M(+151.5%)
Jun 2023
-
$64.09M(+467.5%)
-$68.96M(+48.2%)
Mar 2023
-
$11.29M(+112.9%)
-$133.17M(+7.9%)
DateAnnualQuarterlyTTM
Dec 2022
-$144.63M(>-9900.0%)
-$87.22M(-52.7%)
-$144.63M(-150.7%)
Sep 2022
-
-$57.13M(>-9900.0%)
-$57.68M(-8408.0%)
Jun 2022
-
-$122.00K(+24.2%)
-$678.00K(-18.5%)
Mar 2022
-
-$161.00K(+41.2%)
-$572.00K(+2.4%)
Dec 2021
-$586.00K(-28.5%)
-$274.00K(-126.4%)
-$586.00K(-123.7%)
Sep 2021
-
-$121.00K(-656.3%)
-$262.00K(-85.8%)
Jun 2021
-
-$16.00K(+90.9%)
-$141.00K(-12.8%)
Mar 2021
-
-$175.00K(-450.0%)
-$125.00K(-992.9%)
Dec 2020
-$456.00K(-160.6%)
$50.00K(+238.9%)
$14.00K(+138.9%)
Mar 2020
-
-$36.00K
-$36.00K
Dec 2019
-$175.00K(-2400.0%)
-
-
Dec 2018
-$7000.00
-
-

FAQ

  • What is Tarsus Pharmaceuticals, Inc. annual cash from investing?
  • What is the all-time high annual cash from investing for Tarsus Pharmaceuticals, Inc.?
  • What is Tarsus Pharmaceuticals, Inc. annual cash from investing year-on-year change?
  • What is Tarsus Pharmaceuticals, Inc. quarterly cash from investing?
  • What is the all-time high quarterly cash from investing for Tarsus Pharmaceuticals, Inc.?
  • What is Tarsus Pharmaceuticals, Inc. quarterly cash from investing year-on-year change?
  • What is Tarsus Pharmaceuticals, Inc. TTM cash from investing?
  • What is the all-time high TTM cash from investing for Tarsus Pharmaceuticals, Inc.?
  • What is Tarsus Pharmaceuticals, Inc. TTM cash from investing year-on-year change?

What is Tarsus Pharmaceuticals, Inc. annual cash from investing?

The current annual cash from investing of TARS is -$199.19M

What is the all-time high annual cash from investing for Tarsus Pharmaceuticals, Inc.?

Tarsus Pharmaceuticals, Inc. all-time high annual cash from investing is $140.60M

What is Tarsus Pharmaceuticals, Inc. annual cash from investing year-on-year change?

Over the past year, TARS annual cash from investing has changed by -$339.80M (-241.67%)

What is Tarsus Pharmaceuticals, Inc. quarterly cash from investing?

The current quarterly cash from investing of TARS is -$4.74M

What is the all-time high quarterly cash from investing for Tarsus Pharmaceuticals, Inc.?

Tarsus Pharmaceuticals, Inc. all-time high quarterly cash from investing is $64.09M

What is Tarsus Pharmaceuticals, Inc. quarterly cash from investing year-on-year change?

Over the past year, TARS quarterly cash from investing has changed by -$7.87M (-251.63%)

What is Tarsus Pharmaceuticals, Inc. TTM cash from investing?

The current TTM cash from investing of TARS is -$150.96M

What is the all-time high TTM cash from investing for Tarsus Pharmaceuticals, Inc.?

Tarsus Pharmaceuticals, Inc. all-time high TTM cash from investing is $140.60M

What is Tarsus Pharmaceuticals, Inc. TTM cash from investing year-on-year change?

Over the past year, TARS TTM cash from investing has changed by -$29.19M (-23.97%)
On this page